Medicure Inc. (CVE:MPH – Get Free Report) shares reached a new 52-week low during trading on Monday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 1000 shares. The stock had previously closed at C$0.87.
Medicure Stock Performance
The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of C$8.56 million, a price-to-earnings ratio of -3.28 and a beta of 0.90. The stock’s 50 day moving average is C$0.92 and its 200 day moving average is C$0.99.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Pros And Cons Of Monthly Dividend Stocks
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What is the Dogs of the Dow Strategy? Overview and Examples
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
